Ieva Martinaityte1,2, Elena Kamycheva1,2, Allan Didriksen1, Jette Jakobsen3, Rolf Jorde1,2. 1. Tromsø Endocrine Research Group, Department of Clinical Medicine, UiT The Arctic University of Norway, 9019 Tromsø, Norway. 2. Division of Internal Medicine, University Hospital of North Norway, 9019 Tromsø, Norway. 3. Research Group for Bioactives-Analysis and Application, National Food Institute, Technical University of Denmark, 2800 Lyngby, Denmark.
Abstract
Context:Vitamin D and 25-hydroxyvitamin D [25(OH)D] are stored in adipose tissue, but the clinical relevance is uncertain. Objective: To evaluate changes in serum 25(OH)D and adipose tissue vitamin D levels after stopping vitamin D supplementation. Design: A prospective, double-blind cohort follow-up study. Setting: Clinical Research Unit at University Hospital of North Norway. Patients: Seventy-six subjects were included after participation in a 3- to 5-year prevention of type 2 diabetes study and were administered 20,000 IU of vitamin D or placebo per week. Intervention: During the 12-month follow-up period, blood samples were drawn at the beginning and after 1, 3, 6, 9, and 12 months. Fat biopsies were taken at the start and end. Main Outcome Measures: Changes in 25(OH)D level in serum and 25(OH)D and vitamin D levels in adipose tissue. Results:Forty-one of 42 subjects who were given vitamin D and 33 of 34 subjects who were givenplacebo completed the study. At the inclusion, mean serum 25(OH)D levels were 122 and 71 nmol/L in the vitamin D and placebo groups, respectively. Serum 25(OH)D levels were significantly higher in the vitamin D group than in the placebo group throughout and were 84.5 and 73.1 nmol/L, respectively, after 12 months. In the vitamin D group, adipose tissue vitamin D levels decreased by 52% over 12 months. Conclusion:Vitamin D and 25(OH)D stored in adipose tissue after 3 to 5 years of vitamin D supplementation may have a clinically relevant effect on serum 25(OH)D level the following year.
RCT Entities:
Context:Vitamin D and 25-hydroxyvitamin D [25(OH)D] are stored in adipose tissue, but the clinical relevance is uncertain. Objective: To evaluate changes in serum 25(OH)D and adipose tissue vitamin D levels after stopping vitamin D supplementation. Design: A prospective, double-blind cohort follow-up study. Setting: Clinical Research Unit at University Hospital of North Norway. Patients: Seventy-six subjects were included after participation in a 3- to 5-year prevention of type 2 diabetes study and were administered 20,000 IU of vitamin D or placebo per week. Intervention: During the 12-month follow-up period, blood samples were drawn at the beginning and after 1, 3, 6, 9, and 12 months. Fat biopsies were taken at the start and end. Main Outcome Measures: Changes in 25(OH)D level in serum and 25(OH)D and vitamin D levels in adipose tissue. Results: Forty-one of 42 subjects who were given vitamin D and 33 of 34 subjects who were given placebo completed the study. At the inclusion, mean serum 25(OH)D levels were 122 and 71 nmol/L in the vitamin D and placebo groups, respectively. Serum 25(OH)D levels were significantly higher in the vitamin D group than in the placebo group throughout and were 84.5 and 73.1 nmol/L, respectively, after 12 months. In the vitamin D group, adipose tissue vitamin D levels decreased by 52% over 12 months. Conclusion:Vitamin D and 25(OH)D stored in adipose tissue after 3 to 5 years of vitamin D supplementation may have a clinically relevant effect on serum 25(OH)D level the following year.
Authors: Robert Scragg; Kay-Tee Khaw; Les Toop; John Sluyter; Carlene M M Lawes; Debbie Waayer; Edward Giovannucci; Carlos A Camargo Journal: JAMA Oncol Date: 2018-11-08 Impact factor: 31.777
Authors: George Griffin; Martin Hewison; Julian Hopkin; Rose Anne Kenny; Richard Quinton; Jonathan Rhodes; Sreedhar Subramanian; David Thickett Journal: Clin Med (Lond) Date: 2021-02-16 Impact factor: 2.659
Authors: Tina Shuk-Tin Ip; Sai-Chuen Fu; Michael Tim-Yun Ong; Patrick Shu-Hang Yung Journal: Asia Pac J Sports Med Arthrosc Rehabil Technol Date: 2022-07-02
Authors: Lara Fonseca de Oliveira; Lucas Guimarães de Azevedo; Jerusa da Mota Santana; Luanna Pimenta Carlos de Sales; Marcos Pereira-Santos Journal: Rev Endocr Metab Disord Date: 2020-03 Impact factor: 6.514
Authors: Stefan Pilz; Winfried März; Kevin D Cashman; Mairead E Kiely; Susan J Whiting; Michael F Holick; William B Grant; Pawel Pludowski; Mickael Hiligsmann; Christian Trummer; Verena Schwetz; Elisabeth Lerchbaum; Marlene Pandis; Andreas Tomaschitz; Martin R Grübler; Martin Gaksch; Nicolas Verheyen; Bruce W Hollis; Lars Rejnmark; Spyridon N Karras; Andreas Hahn; Heike A Bischoff-Ferrari; Jörg Reichrath; Rolf Jorde; Ibrahim Elmadfa; Reinhold Vieth; Robert Scragg; Mona S Calvo; Natasja M van Schoor; Roger Bouillon; Paul Lips; Suvi T Itkonen; Adrian R Martineau; Christel Lamberg-Allardt; Armin Zittermann Journal: Front Endocrinol (Lausanne) Date: 2018-07-17 Impact factor: 5.555